MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial

BACKGROUND: Increased usage of genomic risk assessment assays suggests increased reliance on data provided by these assays to guide therapy decisions. The current study aimed to assess the change in treatment decision and physician confidence based on the 70-gene risk of recurrence signature (70-GS,...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Hatem, Shah, Varsha, Srkalovic, Gordan, Mahtani, Reshma, Levine, Ellis, Mavromatis, Blanche, Srinivasiah, Jayanthi, Kassar, Mohamad, Gabordi, Robert, Qamar, Rubina, Untch, Sarah, Kling, Heather M., Treece, Tina, Audeh, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995096/
https://www.ncbi.nlm.nih.gov/pubmed/32005181
http://dx.doi.org/10.1186/s12885-020-6534-z

Ejemplares similares

Ejemplares similares